Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RO4917838 add-on trial in outpatients with schizophrenia and prominent negative or disorganized thought symptoms
2007-002960-85Phase 2Completed
- Sponsor
- Roche
- Start
- Dec 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in schizophrenia comparing RO4917838 add-on with Placebo add-on (2 arms). Primary endpoint: Primary efficacy: change from baseline in PANSS total score at Week 8. Started Dec 2007; status: completed.
02
Drugs
bitopertin
03
Conditions
schizophrenia
Beyond the preview
Go deeper on 2007-002960-85.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002960-85.